/
/
MicroRNA Based Liquid Biopsy: The Experience of the Plasma miRNA Signature Classifier (MSC) for Lung Cancer Screening
This content is Free Access.
15,237 Views
•
08:14 min
•
October 26, 2017
DOI:
Summary
Automatically generated
Here, we present the detailed protocol adopted in the BioMILD screening trial to perform the circulating microRNA signature classifier test for early lung cancer detection.
Read Article
Cite this Article
Mensah, M., Borzi, C., Verri, C., Suatoni, P., Conte, D., Pastorino, U., Orazio, F., Sozzi, G., Boeri, M. MicroRNA Based Liquid Biopsy: The Experience of the Plasma miRNA Signature Classifier (MSC) for Lung Cancer Screening. J. Vis. Exp. (128), e56326, doi:10.3791/56326 (2017).
Copy